| 1 |
34794962 | Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors. | 2022 Feb |
1 |
| 2 |
35464922 | Hepatitis B Virus Pregenomic RNA Reflecting Viral Replication in Distal Non-tumor Tissues as a Determinant of the Stemness and Recurrence of Hepatocellular Carcinoma. | 2022 |
2 |
| 3 |
35580630 | Structural insights into the HBV receptor and bile acid transporter NTCP. | 2022 May 17 |
1 |
| 4 |
35635688 | Genetic variants of NTCP gene and hepatitis B vaccine failure in Taiwanese children of hepatitis B e antigen positive mothers. | 2022 May 30 |
1 |
| 5 |
33445753 | In Vitro Infection with Hepatitis B Virus Using Differentiated Human Serum Culture of Huh7.5-NTCP Cells without Requiring Dimethyl Sulfoxide. | 2021 Jan 12 |
1 |
| 6 |
33456536 | HBV induces liver fibrosis via the TGF-β1/miR-21-5p pathway. | 2021 Feb |
1 |
| 7 |
33617845 | Hyperosmolarity stimulates transporter-mediated insertion of estrone sulfate into the plasma membrane, but inhibits the uptake by SLC10A1 (NTCP). | 2021 Apr |
3 |
| 8 |
33782042 | Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters. | 2021 Jun |
2 |
| 9 |
33807170 | In Vivo Models of HDV Infection: Is Humanizing NTCP Enough? | 2021 Mar 31 |
1 |
| 10 |
34079822 | Substrate Specificities and Inhibition Pattern of the Solute Carrier Family 10 Members NTCP, ASBT and SOAT. | 2021 |
2 |
| 11 |
34266968 | Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis. | 2021 Jul 15 |
2 |
| 12 |
34452397 | Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection. | 2021 Aug 3 |
1 |
| 13 |
34696350 | Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection? | 2021 Sep 24 |
1 |
| 14 |
31722821 | Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors. | 2020 Jan 30 |
8 |
| 15 |
32101444 | In Vitro Functional Characterization and in Silico Prediction of Rare Genetic Variation in the Bile Acid and Drug Transporter, Na+-Taurocholate Cotransporting Polypeptide (NTCP, SLC10A1). | 2020 Apr 6 |
1 |
| 16 |
32316189 | The Lipid Raft Component Stomatin Interacts with the Na+ Taurocholate Cotransporting Polypeptide (NTCP) and Modulates Bile Salt Uptake. | 2020 Apr 16 |
1 |
| 17 |
32568248 | Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells. | 2020 Jun 5 |
1 |
| 18 |
32570893 | Hepatitis B Virus Entry into Cells. | 2020 Jun 18 |
1 |
| 19 |
33078647 | Assessment of Statin Interactions With the Human NTCP Transporter Using a Novel Fluorescence Assay. | 2020 Nov/Dec |
2 |
| 20 |
30639138 | Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity. | 2019 Apr |
6 |
| 21 |
30978651 | The major effective components in Shengmai Formula interact with sodium taurocholate co-transporting polypeptide. | 2019 Jun |
1 |
| 22 |
31018112 | The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA. | 2019 Aug |
1 |
| 23 |
31064734 | Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection model. | 2019 Jun |
1 |
| 24 |
31117968 | Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals. | 2019 May 22 |
1 |
| 25 |
31258056 | The Role of the Sodium-taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) in Related Liver Disease. | 2019 |
1 |
| 26 |
31485670 | hNTCP‑expressing primary pig hepatocytes are a valuable tool for investigating hepatitis B virus infection and antiviral drugs. | 2019 Oct |
1 |
| 27 |
32039379 | Mechanistic insights into the inhibition of NTCP by myrcludex B. | 2019 Oct |
2 |
| 28 |
29212823 | Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes. | 2018 Feb |
1 |
| 29 |
29805766 | Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide. | 2018 May 4 |
1 |
| 30 |
30032030 | The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency. | 2018 Sep |
1 |
| 31 |
30556041 | Calnexin Depletion by Endoplasmic Reticulum Stress During Cholestasis Inhibits the Na+-Taurocholate Cotransporting Polypeptide. | 2018 Dec |
1 |
| 32 |
28962642 | Upregulation of sodium taurocholate cotransporter polypeptide during hepatogenic differentiation of umbilical cord matrix mesenchymal stem cells facilitates hepatitis B entry. | 2017 Sep 29 |
1 |
| 33 |
27251172 | Reciprocal regulation of farnesoid X receptor α activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes. | 2016 Sep |
1 |
| 34 |
27676153 | Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis. | 2016 Oct 17 |
1 |
| 35 |
27784961 | Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule. | 2016 Oct 14 |
1 |
| 36 |
25690737 | Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes. | 2015 May |
1 |
| 37 |
25765005 | Interleukin 6 inhibits HBV entry through NTCP down regulation. | 2015 Jul |
2 |
| 38 |
25929767 | The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide. | 2015 |
1 |
| 39 |
24295872 | Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. | 2014 Apr |
1 |
| 40 |
24375637 | Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). | 2014 May |
1 |
| 41 |
24390325 | Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. | 2014 Mar |
1 |
| 42 |
24754247 | Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3. | 2014 Jun 2 |
1 |
| 43 |
24768844 | Strategies to inhibit entry of HBV and HDV into hepatocytes. | 2014 Jul |
1 |
| 44 |
24965018 | In silico analysis and experimental validation of azelastine hydrochloride (N4) targeting sodium taurocholate co-transporting polypeptide (NTCP) in HBV therapy. | 2014 Aug |
2 |
| 45 |
25168282 | Electrophysiological characterization of human Na⁺/taurocholate cotransporting polypeptide (hNTCP) heterologously expressed in Xenopus laevis oocytes. | 2014 Nov 15 |
8 |
| 46 |
23886862 | Cysteine 96 of Ntcp is responsible for NO-mediated inhibition of taurocholate uptake. | 2013 Oct 1 |
9 |
| 47 |
22029531 | Homo- and hetero-dimeric architecture of the human liver Na⁺-dependent taurocholate co-transporting protein. | 2012 Feb 1 |
1 |
| 48 |
22641618 | In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity. | 2012 Sep |
1 |
| 49 |
22897388 | Expression and transport function of drug uptake transporters in differentiated HepaRG cells. | 2012 Dec 3 |
1 |
| 50 |
20946088 | Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. | 2011 Jan |
2 |